P

Inventor

HOROWITZ BERNARD

US28 patents
⚠️ This page may combine multiple inventors who share the name “HOROWITZ BERNARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEW YORK BLOOD CENTER INC

21 patents
US4540573ASep 10, 1985

Undenatured virus-free biologically active protein derivatives

NEW YORK BLOOD CENTER INC253 citations99
US6087141AJul 11, 2000

Process for the sterilization of biological compositions and the product produced thereby

NEW YORK BLOOD CENTER INC102 citations98
US5981163ANov 9, 1999

Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions

NEW YORK BLOOD CENTER INC91 citations97
US5789150AAug 4, 1998

Process for the sterilization of biological compositions using UVA1 irradiation

NEW YORK BLOOD CENTER INC41 citations96
US5658722AAug 19, 1997

Process for the sterilization of biological compositions using UVA1 irradiation

NEW YORK BLOOD CENTER INC68 citations96
US5637451AJun 10, 1997

Photodynamic treatment of red blood cells with phthalocyanines and red light at higher light fluence rates is protective of red blood cells

NEW YORK BLOOD CENTER INC65 citations96
US5232844AAug 3, 1993

Photodynamic inactivation of viruses in cell-containing compositions

NEW YORK BLOOD CENTER INC115 citations96
US5120649AJun 9, 1992

Photodynamic inactivation of viruses in blood cell-containing compositions

NEW YORK BLOOD CENTER INC128 citations96
US4841023AJun 20, 1989

Inactivation of viruses in labile protein-containing compositions using fatty acids

NEW YORK BLOOD CENTER INC68 citations96
US4764369AAug 16, 1988

Undenatured virus-free biologically active protein derivatives

NEW YORK BLOOD CENTER INC93 citations96
US4613501ASep 23, 1986

Inactivation of viruses in labile blood derivatives

NEW YORK BLOOD CENTER INC102 citations96
US5712086AJan 27, 1998

Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions

NEW YORK BLOOD CENTER INC89 citations95
US5858643AJan 12, 1999

Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process

NEW YORK BLOOD CENTER INC41 citations94
US4909940AMar 20, 1990

Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons

NEW YORK BLOOD CENTER INC88 citations93
US5541294AJul 30, 1996

Removal of antibodies from blood-derived compositions while retaining coagulation factors

NEW YORK BLOOD CENTER INC37 citations92
US4820805AApr 11, 1989

Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives

NEW YORK BLOOD CENTER INC37 citations92
US6077659AJun 20, 2000

Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light

NEW YORK BLOOD CENTER INC27 citations91
US5055485AOct 8, 1991

Inactivation of viruses in cell- and protein-containing compositions using aryl diol epoxides

NEW YORK BLOOD CENTER INC40 citations91
US5514647AMay 7, 1996

Fibronectin-containing ophthalmic solution, method of preserving an opthalmic solution, and methods of treatment of opthalmic wounds

NEW YORK BLOOD CENTER INC16 citations78
US5677162AOct 14, 1997

Method for activating prothrombin to thrombin

NEW YORK BLOOD CENTER INC13 citations66
US5348939ASep 20, 1994

Fibronectin-containing ophthalmic solution, method of preserving an ophthalmic solution, and method of treatment of ophthalmic wounds

NEW YORK BLOOD CENTER INC5 citations59

NEW YORK BLOOD CT INC

5 patents

HOROWITZ HARVEY J

1 patent

REAL TIME ELECTRONICS CORP

1 patent